Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action

Graphical abstract

• Publication year

  2020

• Venue

  Biochemical Pharmacology

• Publication date

  2020-10-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.bcp.2020.114296PMID 33191206PMCID 7581400
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The in-vitro effect of famotidine on sars-cov-2 proteases and virus replication

  2021cited by this paper
• Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial

  2021cited by this paper
• Emerging coronaviruses: Genome structure, replication, and pathogenesis

  2020cited by this paper
• Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

  2020cited by this paper
• Potential inhibitors against 2019-nCoV coronavirus M protease from clinically approved medicines

  2020cited by this paper
• Kinins and Cytokines in COVID-19: A Comprehensive Pathophysiological Approach

  2020cited by this paper
• The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro

  2020cited by this paper
• Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19

  2020cited by this paper
• Nelfinavir inhibits replication of severe acute respiratory syndrome coronavirus 2 in vitro

  2020cited by this paper
• Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

  2020cited by this paper
• Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19

  2020cited by this paper
• Remdesivir and SARS-CoV-2: Structural requirements at both nsp12 RdRp and nsp14 Exonuclease active-sites

  2020cited by this paper
• The Novel Insight of SARS-CoV-2 Molecular Biology and Pathogenesis and Therapeutic Options

  2020cited by this paper
• Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing

  2020cited by this paper
• Successful use of methylprednisolone for treating severe COVID-19

  2020cited by this paper
• Discovery of potential multi-target-directed ligands by targeting host-specific SARS-CoV-2 structurally conserved main protease

  2020cited by this paper
• Chloroquine does not inhibit infection of human lung cells with SARS-CoV-2

  2020cited by this paper
• Coronavirus Disease 2019 Pneumonia in Immunosuppressed Renal Transplant Recipients: A Summary of 10 Confirmed Cases in Wuhan, China

  2020cited by this paper
• Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro

  2020cited by this paper
• Cytokine storm and colchicine potential role fighting SARS-CoV-2 pneumonia

  2020cited by this paper
• A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir

  2020cited by this paper
• Remdesivir

  2020cited by this paper
• Glycyrrhizin

  2020cited by this paper
• Famotidine Use Is Associated With Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study

  2020cited by this paper
• A retrospective cohort study of methylprednisolone therapy in severe patients with COVID-19 pneumonia

  2020cited by this paper
• Beneficial effects of colchicine for moderate to severe COVID-19: an interim analysis of a randomized, double-blinded, placebo controlled clinical trial

  2020cited by this paper
• Kallikrein-kinin blockade in patients with COVID-19 to prevent acute respiratory distress syndrome

  2020cited by this paper
• Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study

  2020influential reference
• Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19

  2020cited by this paper
• Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

  2020influential reference
• Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

  2020cited by this paper
• Remdesivir for the Treatment of Covid-19 — Final Report

  2020cited by this paper
• Identification of potential treatments for COVID-19 through artificial intelligence-enabled phenomic analysis of human cells infected with SARS-CoV-2

  2020cited by this paper
• A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping

  2020cited by this paper
• New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?

  2020cited by this paper
• Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19

  2020cited by this paper
• Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019

  2020cited by this paper
• The Structural Landscape of SARS-CoV-2 Main Protease: Hints for Inhibitor Search.

  2020cited by this paper
• The Effect of Famotidine on SARS-CoV-2 Proteases and Virus Replication

  2020cited by this paper
• Arbidol: A potential antiviral drug for the treatment of SARS-CoV-2 by blocking trimerization of the spike glycoprotein

  2020cited by this paper
• Clinical trials on drug repositioning for COVID-19 treatment

  2020cited by this paper
• The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an antiviral against COVID‐19 infections

  2020cited by this paper
• Effective treatment of severe COVID-19 patients with tocilizumab

  2020cited by this paper
• Prolonged Low-Dose Methylprednisolone in Patients With Severe COVID-19 Pneumonia

  2020cited by this paper
• Concentration-dependent mortality of chloroquine in overdose

  2020cited by this paper
• Correction to Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19

  2020cited by this paper
• Cell entry mechanisms of SARS-CoV-2

  2020cited by this paper
• Risk of hydroxychloroquine alone and in combination with azithromycin in the treatment of rheumatoid arthritis: a multinational, retrospective study

  2020influential reference
• TMPRSS2 and COVID-19: Serendipity or opportunity for intervention?

  2020cited by this paper
• Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies.

  2020cited by this paper
• Novel coronavirus treatment with ribavirin: Groundwork for an evaluation concerning COVID‐19

  2020cited by this paper
• Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection

  2020cited by this paper
• The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells

  2020cited by this paper
• A hypothesized role for dysregulated bradykinin signaling in COVID‐19 respiratory complications

  2020cited by this paper
• Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China

  2020cited by this paper
• SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

  2020influential reference
• Pathological findings of COVID-19 associated with acute respiratory distress syndrome

  2020cited by this paper
• Coronavirus membrane fusion mechanism offers a potential target for antiviral development

  2020cited by this paper
• Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial

  2020cited by this paper
• Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells

  2020cited by this paper
• Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV

  2020cited by this paper
• Potential Treatments for COVID-19; a Narrative Literature Review

  2020cited by this paper
• Valrubicin

  2020cited by this paper
• Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2

  2020cited by this paper
• Compassionate Use of Remdesivir for Patients with Severe Covid-19

  2020cited by this paper
• A pneumonia outbreak associated with a new coronavirus of probable bat origin

  2020cited by this paper
• Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

  2020cited by this paper
• The Greek study in the effects of colchicine in COvid-19 complications prevention (GRECCO-19 study): Rationale and study design

  2020cited by this paper
• Remdesivir: A Review of Its Discovery and Development Leading to Human Clinical Trials for Treatment of COVID-19

  2020cited by this paper
• Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

  2020cited by this paper
• Famotidine use and quantitative symptom tracking for COVID-19 in non-hospitalised patients: a case series

  2020cited by this paper
• Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

  2020cited by this paper
• Delayed Initiation of Remdesivir in a COVID‐19‐Positive Patient

  2020cited by this paper
• Clinical characteristics and immunosuppressant management of coronavirus disease 2019 in solid organ transplant recipients

  2020cited by this paper
• Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.

  2020cited by this paper
• Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

  2020cited by this paper
• Molecular mechanisms of action of hesperidin in cancer: Recent trends and advancements

  2020cited by this paper
• Drug targets for corona virus: A systematic review

  2020cited by this paper
• An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice

  2020cited by this paper
• SARS-CoV-2 infection: The role of cytokines in COVID-19 disease

  2020influential reference
• Candidate drugs against SARS-CoV-2 and COVID-19

  2020cited by this paper
• SARS-CoV-2 Entry Genes Are Most Highly Expressed in Nasal Goblet and Ciliated Cells within Human Airways

  2020cited by this paper
• Inhibitory effects of orientin in mast cell-mediated allergic inflammation

  2020cited by this paper
• Emetine exhibits anticancer activity in breast cancer cells as an antagonist of Wnt/β-catenin signaling

  2019cited by this paper
• Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia

  2019cited by this paper
• Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir

  2019cited by this paper
• The Regulatory Effects of Paeoniflorin and Its Derivative Paeoniflorin-6′-O-Benzene Sulfonate CP-25 on Inflammation and Immune Diseases

  2019cited by this paper
• Polyphyllin I induces autophagy and cell cycle arrest via inhibiting PDK1/Akt/mTOR signal and downregulating cyclin B1 in human gastric carcinoma HGC-27 cells.

  2019cited by this paper
• Structural insights into coronavirus entry

  2019cited by this paper
• Protostemonine alleviates heat-killed methicillin-resistant Staphylococcus aureus-induced acute lung injury through MAPK and NF-κB signaling pathways.

  2019cited by this paper
• The NLRP3 inflammasome: molecular activation and regulation to therapeutics

  2019cited by this paper
• Hydroxychloroquine

  2019cited by this paper
• Cromolyn sodium delays disease onset and is neuroprotective in the SOD1G93A Mouse Model of amyotrophic lateral sclerosis

  2019cited by this paper
• Antioxidant and Anti-inflammatory Mechanisms of Neuroprotection by Ursolic Acid: Addressing Brain Injury, Cerebral Ischemia, Cognition Deficit, Anxiety, and Depression

  2019cited by this paper
• Isolation and Identification of Myricitrin, an Antioxidant Flavonoid, from Daebong Persimmon Peel

  2018cited by this paper
• PubChem 2019 update: improved access to chemical data

  2018cited by this paper
• Anticancer effects and underlying mechanism of Colchicine on human gastric cancer cell lines in vitro and in vivo

  2018cited by this paper
• TMEM106B drives lung cancer metastasis by inducing TFEB-dependent lysosome synthesis and secretion of cathepsins

  2018cited by this paper
• Corynoline Exhibits Anti-inflammatory Effects in Lipopolysaccharide (LPS)-Stimulated Human Umbilical Vein Endothelial Cells through Activating Nrf2

  2018cited by this paper
• Retrograde axonal transport of rabies virus is unaffected by interferon treatment but blocked by emetine locally in axons

  2018cited by this paper

• MG-101, a cysteine protease inhibitor identified through high-throughput screening, exhibits in vivo efficacy and synergy with remdesivir against SARS-CoV-2.

  2026cites this paper
• Gene Expression Profiles in the Optic Nerve of Mice with Systemic Acanthamoebiasis

  2026cites this paper
• Computational Repurposing of Relatively Large Drugs for the Receptor Binding Domain of SARS‐CoV‐2 Spike Protein

  2025cites this paper
• Emetine dihydrochloride inhibits Chikungunya virus nsP2 helicase and shows antiviral activity in the cell culture and mouse model of virus infection

  2025cites this paper
• A deep generative model for deciphering cellular dynamics and in silico drug discovery in complex diseases

  2025cites this paper
• An updated and comprehensive review of the health benefits and pharmacological activities of hesperidin.

  2025cites this paper
• Aptamer-based biosensors for wastewater surveillance of influenza virus, SARS-CoV-2, and norovirus: A comprehensive review.

  2025cites this paper
• Drug Repurposing and Artificial Intelligence in Multiple Sclerosis: Emerging Strategies for Precision Therapy

  2025cites this paper
• Emetine: Advances in Pharmacology, Toxicology, and Chromatographic Approaches.

  2025cites this paper
• Targeted screening and rational optimization of bazedoxifene analogs as pan-variant SARS-CoV-2 entry inhibitors with improved pharmacokinetics.

  2025cites this paper
• AI and Machine Learning in Modern Drug Design and Discovery

  2025cites this paper
• Ethnobotanical survey of herbal medicines for anti-COVID-19 used by traditional Chinese medicine pharmacies in Taiwan

  2025cites this paper
• In silico screening and experimental validation identify riboflavin as an RNA-targeted antiviral against SARS-CoV-2

  2025cites this paper
• Famotidine for COVID-19

  2024cites this paper
• Anti-rheumatic colchicine phytochemical exhibits potent antiviral activities against avian and seasonal Influenza A viruses (IAVs) via targeting different stages of IAV replication cycle

  2024cites this paper
• Comparable Clinical Advantages Identification of Three Formulae on Rheumatic Disease Using a Modular-based Network Proximity Approach.

  2024cites this paper
• Вплив демографічних та клінічних чинників на летальність при коронавірусній хворобі в пацієнтів із тяжким та критичним перебігом

  2024cites this paper
• A comprehensive molecular docking-based study to identify potential drug-candidates against the novel and emerging severe fever with thrombocytopenia syndrome virus (SFTSV) by targeting the nucleoprotein

  2024cites this paper
• Emetine induces oxidative stress, cell differentiation and NF-κB inhibition, suppressing AML stem/progenitor cells

  2024cites this paper
• In vitro pharmacokinetic behavior in lung of harringtonine, an antagonist of SARS-CoV-2 associated proteins: New insights of inhalation therapy for COVID-19.

  2024cites this paper
• Sodium Cromolyn Modulates Carrageenan-Induced Acute Inflammation Through the Interleukin-6 Levels

  2024cites this paper
• Three-Day Icatibant on Top of Standard Care in Patients With Coronavirus Disease 2019 Pneumonia: A Randomized, Open-Label, Phase 2, Proof-of-Concept Trial

  2023cites this paper
• Artificial intelligence assessment of the potential of tocilizumab along with corticosteroids therapy for the management of COVID-19 evoked acute respiratory distress syndrome

  2023cites this paper
• An update on the development of antiviral against Mayaro virus: from molecules to potential viral targets

  2023cites this paper
• A systematic review on impact of SARS-CoV-2 infection

  2023cites this paper
• Drug repositioning in the COVID-19 pandemic: fundamentals, synthetic routes, and overview of clinical studies

  2023cites this paper
• Recombinant Bacillus Calmette-Guérin Expressing SARS-CoV-2 Chimeric Protein Protects K18-hACE2 Mice against Viral Challenge.

  2023cites this paper
• A placental model of SARS-CoV-2 infection reveals ACE2-dependent susceptibility and differentiation impairment in syncytiotrophoblasts

  2023cites this paper
• De Novo Drug Design of Potential Inhibitors of SARS-CoV-2 Papain-like Protease

  2023cites this paper
• A peptide derived from HSP60 reduces proinflammatory cytokines and soluble mediators: a therapeutic approach to inflammation

  2023cites this paper
• Deciphering the Relationship between SARS-CoV-2 and Cancer

  2023cites this paper
• Unagi: Deep Generative Model for Deciphering Cellular Dynamics and In-Silico Drug Discovery in Complex Diseases

  2023cites this paper
• Using TransR to Enhance Drug Repurposing Knowledge Graph for COVID-19 and its Complications.

  2023cites this paper
• Recent progress on drugs discovery study for treatment of COVID-19: repurposing existing drugs and current natural bioactive molecules

  2023cites this paper
• COVID‐19 and cancer: Dichotomy of the menacing dilemma

  2023cites this paper
• Molecular Simulation of the Effect of Electron Donor/Acceptor Groups on Fluvoxamine/Serotonin Interactions as a Strategy for COVID‐19 Mitigation

  2023cites this paper
• Update on Remdesivir in the Treatment of Novel Coronavirus Pneumonia

  2023influential citation
• Co-administration of AYUSH 64 as an adjunct to standard of care in mild and moderate COVID-19: A randomized, controlled, multicentric clinical trial

  2023cites this paper
• Challenges of Multiplex Assays for COVID-19 Research: A Machine Learning Perspective.

  2022cites this paper
• Pharmaco-immunomodulatory interventions for averting cytokine storm-linked disease severity in SARS-CoV-2 infection

  2022cites this paper
• Neuropsychiatric Drugs Against COVID-19: What is the Clinical Evidence?

  2022cites this paper
• Clinical outcomes of immunomodulatory therapies in the management of COVID-19: A tertiary-care experience from Pakistan

  2022cites this paper
• Safety profile of COVID-19 drugs in a real clinical setting

  2022cites this paper
• Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies

  2022cites this paper
• Prescription Patterns of Drugs Given to Hospitalized COVID-19 Patients: A Cross-Sectional Study in Colombia

  2022cites this paper
• Molnupiravir, favipiravir and other antiviral drugs with proposed potentials for management of COVID-19: a concern on antioxidant aspect.

  2022cites this paper
• In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking

  2022cites this paper
• Repurposing of Four Drugs as Anti-SARS-CoV-2 Agents and Their Interactions with Protein Targets

  2022cites this paper
• Potential of sphingosine-1-phosphate in preventing SARS-CoV-2 infection by stabilizing and protecting endothelial cells

  2022cites this paper
• Efficacy of oseltamivir in the treatment of patients infected with Covid-19

  2022cites this paper
• COVID-19 and the role of cytokines in this disease

  2022cites this paper
• Skeletal Muscle and COVID-19: The Potential Involvement of Bioactive Sphingolipids

  2022cites this paper
• High-throughput drug screening allowed identification of entry inhibitors specifically targeting different routes of SARS-CoV-2 Delta and Omicron/BA.1

  2022influential citation
• Drugs repurposing for SARS-CoV-2: new insight of COVID-19 druggability

  2022cites this paper
• Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods

  2022cites this paper
• Total Controllability Analysis Discovers Explainable Drugs for Covid-19 Therapy and Prevention

  2022cites this paper
• Treatment of Covid 19 Infection with Oselatamivir as First Line Antiviral Therapy for Non-Hospitalized Patients

  2022cites this paper
• Molecular docking and molecular dynamic simulation approaches for drug development and repurposing of drugs for severe acute respiratory syndrome-Coronavirus-2

  2022cites this paper
• Role of H2 receptor blocker famotidine over the clinical recovery of COVID-19 patients: A randomized controlled trial

  2022cites this paper
• Evaluations of FDA-approved drugs targeting 3CLP of SARS-CoV-2 employing a repurposing strategy.

  2022cites this paper
• Lung Organoids as Model to Study SARS-CoV-2 Infection

  2022cites this paper
• Progress, pitfalls, and path forward of drug repurposing for COVID-19 treatment

  2022cites this paper
• Design, synthesis, and biological evaluation of novel ruxolitinib and baricitinib analogues for potential use against COVID‐19

  2022cites this paper
• Viral proteases as therapeutic targets

  2022cites this paper
• Inhibition of coronavirus HCoV-OC43 by targeting the eIF4F complex

  2022influential citation
• Nelfinavir: An Old Ally in the COVID-19 Fight?

  2022cites this paper
• Design, synthesis, and greener pasture biological assessment of a novel nucleoside: 1-(α-D-ribofuranosyl)-6,7-difluoro-2-methyl-4-quinazolinone as an inhibitor of COVID-19 and Alzheimer’s disease

  2022cites this paper
• BioScientific Review (BSR)

  2022influential citation
• Computational repurposing approach for targeting the critical spike mutations in B.1.617.2 (delta), AY.1 (delta plus) and C.37 (lambda) SARS-CoV-2 variants using exhaustive structure-based virtual screening, molecular dynamic simulations and MM-PBSA methods

  2022cites this paper
• The Place of Fluvoxamine in the Treatment of Non-critically ill Patients with COVID-19: A Living Systematic Review and Meta-analysis

  2021cites this paper
• COVID-19: Immune Perspective and Current Treatment Strategies

  2021influential citation
• Life-long passion for antiviral research and drug development: 80th birthday of Prof. Dr. Erik De Clercq

  2021cites this paper
• Races of small molecule clinical trials for the treatment of COVID‐19: An up‐to‐date comprehensive review

  2021cites this paper
• Characteristics of published/registered clinical trials on COVID-19 treatment: A systematic review

  2021cites this paper
• Identification of genotypic variants and its proteomic mutations of Brazilian SARS-CoV-2 isolates

  2021cites this paper
• A Drug Repurposing Approach for Antimalarials Interfering with SARS-CoV-2 Spike Protein Receptor Binding Domain (RBD) and Human Angiotensin-Converting Enzyme 2 (ACE2)

  2021cites this paper
• Pathogenic Mitochondrial Dysfunction and Metabolic Abnormalities.

  2021cites this paper
• Ongoing Clinical Trials and the Potential Therapeutics for COVID-19 Treatment

  2021cites this paper
• A novel method of literature mining to identify candidate COVID-19 drugs

  2021cites this paper
• Sphingolipids in Lung Pathology in the Coronavirus Disease Era: A Review of Sphingolipid Involvement in the Pathogenesis of Lung Damage

  2021cites this paper
• Drug Discovery of Nucleos(t)ide Antiviral Agents: Dedicated to Prof. Dr. Erik De Clercq on Occasion of His 80th Birthday

  2021cites this paper
• Host Cell and SARS-CoV-2-Associated Molecular Structures and Factors as Potential Therapeutic Targets

  2021cites this paper
• Colchicine in Recently Hospitalized Patients with COVID-19: A Randomized Controlled Trial (COL-COVID)

  2021cites this paper
• Rutaretin1′-(6″-sinapoylglucoside): promising inhibitor of COVID 19 mpro catalytic dyad from the leaves of Pittosporum dasycaulon miq (Pittosporaceae)

  2021cites this paper
• Asunaprevir, a Potent Hepatitis C Virus Protease Inhibitor, Blocks SARS-CoV-2 Propagation

  2021cites this paper
• Identification of potential therapeutic targets and mechanisms of COVID-19 through network analysis and screening of chemicals and herbal ingredients

  2021cites this paper
• SARS-CoV-2: lessons from both the history of medicine and from the biological behavior of other well-known viruses

  2021cites this paper
• Geraniin Inhibits the Entry of SARS-CoV-2 by Blocking the Interaction between Spike Protein RBD and Human ACE2 Receptor

  2021cites this paper
• Therapeutic targets and interventional strategies in COVID-19: mechanisms and clinical studies

  2021cites this paper
• Repurposing the estrogen receptor modulator raloxifene to treat SARS-CoV-2 infection

  2021cites this paper
• Executable network of SARS-CoV-2-host interaction predicts drug combination treatments

  2021cites this paper
• Cytokine Storm Syndrome in SARS-CoV-2 Infections: A Functional Role of Mast Cells

  2021cites this paper
• Computational identification of repurposed drugs against viruses causing epidemics and pandemics via drug-target network analysis

  2021cites this paper
• Repurposing NASVAC, a hepatitis B therapeutic vaccine, for pre- and postexposure prophylaxis of SARS-CoV-2 infection

  2021cites this paper
• Coadministration of AYUSH 64 as an adjunct to Standard of Care in mild and moderate COVID-19: A randomised, controlled, multicentric clinical trial

  2021cites this paper
• The Effect of COVID-19 on NF-κB and Neurological Manifestations of Disease

  2021cites this paper
• DEEMD: Drug Efficacy Estimation Against SARS-CoV-2 Based on Cell Morphology With Deep Multiple Instance Learning

  2021cites this paper
• The Structure-Based Design of SARS-CoV-2 nsp14 Methyltransferase Ligands Yields Nanomolar Inhibitors

  2021cites this paper
• BIOMEDICAL RESEARCHERS CONFRONTING THE COVID-19 PANDEMIC

  2021cites this paper
• Mediterranean Diet for the Prevention of Gestational Diabetes in the Covid-19 Era: Implications of Il-6 In Diabesity

  2021cites this paper